News (All) | My Site

GIE Medical News

GIE Medical Announces First Patient Enrolled in PATENT-B Benign Bowel Stricture Treatment Study

Apr 18, 2024

The large, multicenter randomized controlled clinical trial is evaluating the safety and efficacy of the ProTractX3™ TTS drug coated balloon for the treatment of benign bowel strictures.

From iGIE - GIE Medical's Drug Coated Balloon for Esophageal Strictures Shows Promising Results

Dec 19, 2023

iGIE published initial findings from the INGEST Study that examined the development and initial clinical experience with ProTractX3 DCB for the treatment of benign difficult esophageal strictures

GIE Medical Announces First Patient Enrolled in PATENT-E Benign Esophageal Stricture Treatment Study

Dec 8, 2023

The large, multicenter randomized controlled clinical trial is evaluating the safety and efficacy of the ProTractX3™ TTS drug coated balloon for the treatment of benign esophageal strictures.

GIE Medical Granted FDA's Breakthrough Device Designation for Multi-Stage Drug Coated Balloon to Treat Esophageal Strictures

Jun 6, 2023

Designation may provide U.S. patients faster access to groundbreaking technology

GIE Medical Launches Two Clinical Trials to Investigate Use of a Multi-Stage Drug Coated Balloon in Esophageal and Bowel Strictures

Dec 13, 2022

First Patients Have Already Been Treated, with Active Enrollment in Trials Continuing Throughout U.S.

Drug-Coated Balloon Might Be Major Advance for Refractory Strictures

Jun 23, 2021

A balloon coated with the anticancer agent paclitaxel appears to hold significant promise for the treatment of patients with complicated esophageal stents.